These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15870666

  • 1. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.
    Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M.
    J Pediatr; 2005 May; 146(5):632-7. PubMed ID: 15870666
    [Abstract] [Full Text] [Related]

  • 2. Trial of early neonatal hydrocortisone: two-year follow-up.
    Peltoniemi OM, Lano A, Puosi R, Yliherva A, Bonsante F, Kari MA, Hallman M, Neonatal Hydrocortisone Working Group.
    Neonatology; 2009 May; 95(3):240-7. PubMed ID: 18931525
    [Abstract] [Full Text] [Related]

  • 3. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.
    Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, Couser RJ, Garland JS, Rozycki HJ, Leach CL, Backstrom C, Shaffer ML.
    Pediatrics; 2004 Dec; 114(6):1649-57. PubMed ID: 15574629
    [Abstract] [Full Text] [Related]

  • 4. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO, Anstead MI, Shook LA.
    Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598
    [Abstract] [Full Text] [Related]

  • 5. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.
    Watterberg KL, Scott SM.
    Pediatrics; 1995 Jan 05; 95(1):120-5. PubMed ID: 7770288
    [Abstract] [Full Text] [Related]

  • 6. Early hypoadrenalism in premature infants at risk for bronchopulmonary dysplasia or death.
    Nykänen P, Anttila E, Heinonen K, Hallman M, Voutilainen R.
    Acta Paediatr; 2007 Nov 05; 96(11):1600-5. PubMed ID: 17888053
    [Abstract] [Full Text] [Related]

  • 7. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
    Wadhawan R, Oh W, Perritt R, Laptook AR, Poole K, Wright LL, Fanaroff AA, Duara S, Stoll BJ, Goldberg R.
    J Perinatol; 2007 Jun 05; 27(6):359-64. PubMed ID: 17443198
    [Abstract] [Full Text] [Related]

  • 8. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
    Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, Vincer M, TIPP Investigators.
    J Pediatr; 2006 Jun 05; 148(6):730-734. PubMed ID: 16769377
    [Abstract] [Full Text] [Related]

  • 9. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, Stoll BJ, Poole K, Wright LL, Neonatal Research Network.
    J Pediatr; 2005 Dec 05; 147(6):786-90. PubMed ID: 16356432
    [Abstract] [Full Text] [Related]

  • 10. Fluticasone inhalation in moderate cases of bronchopulmonary dysplasia.
    Dugas MA, Nguyen D, Frenette L, Lachance C, St-Onge O, Fougères A, Bélanger S, Caouette G, Proulx E, Racine MC, Piedboeuf B.
    Pediatrics; 2005 May 05; 115(5):e566-72. PubMed ID: 15833887
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
    Morris IP, Goel N, Chakraborty M.
    Eur J Pediatr; 2019 Aug 05; 178(8):1171-1184. PubMed ID: 31144162
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic postnatal corticosteroids: Early hydrocortisone.
    Baud O, Watterberg KL.
    Semin Fetal Neonatal Med; 2019 Jun 05; 24(3):202-206. PubMed ID: 31043325
    [Abstract] [Full Text] [Related]

  • 13. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F.
    Pediatrics; 2006 Jun 05; 117(6):e1213-22. PubMed ID: 16717120
    [Abstract] [Full Text] [Related]

  • 14. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
    Rademaker KJ, Uiterwaal CS, Groenendaal F, Venema MM, van Bel F, Beek FJ, van Haastert IC, Grobbee DE, de Vries LS.
    J Pediatr; 2007 Apr 05; 150(4):351-7. PubMed ID: 17382109
    [Abstract] [Full Text] [Related]

  • 15. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
    Laughon M, Bose C, Moya F, Aschner J, Donn SM, Morabito C, Cummings JJ, Segal R, Guardia C, Liu G, Surfaxin Study Group.
    Pediatrics; 2009 Jan 05; 123(1):89-96. PubMed ID: 19117865
    [Abstract] [Full Text] [Related]

  • 16. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L.
    Ann Thorac Surg; 2006 Jan 05; 81(1):231-4. PubMed ID: 16368371
    [Abstract] [Full Text] [Related]

  • 17. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants.
    Bhandari V, Bergqvist LL, Kronsberg SS, Barton BA, Anand KJ, NEOPAIN Trial Investigators Group.
    Pediatrics; 2005 Aug 05; 116(2):352-9. PubMed ID: 16061589
    [Abstract] [Full Text] [Related]

  • 18. Antenatal steroids and risk of bronchopulmonary dysplasia: a lack of effect or a case of over-adjustment?
    Gagliardi L, Bellù R, Rusconi F, Merazzi D, Mosca F.
    Paediatr Perinat Epidemiol; 2007 Jul 05; 21(4):347-53. PubMed ID: 17564592
    [Abstract] [Full Text] [Related]

  • 19. Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
    Renolleau C, Toumazi A, Bourmaud A, Benoist JF, Chevenne D, Mohamed D, Alberti C, Biran V, Baud O, PREMILOC Trial Study Group.
    J Pediatr; 2021 Jul 05; 234():65-70.e3. PubMed ID: 33359303
    [Abstract] [Full Text] [Related]

  • 20. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants.
    Kersbergen KJ, de Vries LS, van Kooij BJ, Išgum I, Rademaker KJ, van Bel F, Hüppi PS, Dubois J, Groenendaal F, Benders MJ.
    J Pediatr; 2013 Sep 05; 163(3):666-71.e1. PubMed ID: 23706359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.